Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.41 |
| ▸ | CCR1 | P32246 | 2/20 | 0.41 |
| ▸ | CCR5 | P51681 | 2/20 | 0.41 |
| ▸ | CCR8 | P51685 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1407987 | 0.85 | LMNA (0.35) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL28588858 | 0.84 | LMNA (0.38) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL6512183 | 0.83 | KDM4E (0.44) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL9710399 | 0.81 | FURIN (0.36) | KDM4ETSHRSLC22A6HPGD | |
| SCHEMBL1360826 | 0.79 | LMNA (0.41) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL1407984 | 0.79 | KDM4E (0.41) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL6220452 | 0.79 | TDP1 (0.43) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL23611463 | 0.78 | KDM4E (0.39) | LMNAKDM4EP4HTMCCR1CCR5 | |
| SCHEMBL11554272 | 0.78 | PTGS2 (0.40) | LMNAKDM4EP4HTMCCR1CCR5 | |
| Sulfuric Acid SCHEMBL30276348 | 0.78 | POLB (0.42) | LMNAKDM4EP4HTMCCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115803418-A | Water-soluble metal working oil | 出光兴产株式会社 | 2023-03-14 | — | — | CN | disclosed |
| US-8198020-B2 | Contacting target cell or noncellular molecular entity with phagocytic marker and moiety that binds to a component that is present on or at surface of target cell or noncellular molecular entity, thereby increasing level or density of phagocytic marker on target cell; marker comprises phosphatidylserine | POTENTIA PHARMACEUTICALS, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| EP-1553086-B1 | PROCESS FOR PRODUCING 5-(2 '-PYRIDYL)-2-PYRIDONE DERIVATIVE | KURARAY CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-7479571-B2 | Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins | CERNOFINA, LLC (US) | 2009-01-20 | — | — | US | disclosed |
| US-7479571-B2 | Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins | CERNOFINA, LLC (US) | 2009-01-20 | — | — | US | disclosed |
| EP-1553086-A4 | PROCESS FOR PRODUCING 5-(2 '-PYRIDYL)-2-PYRIDONE DERIVATIVE | KURARAY CO (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-20050113297-A1 | Compositions and methods for enhancing phagocytosis or phagocyte activity | POTENTIA PHARMACEUTICALS, INC. | 2005-05-26 | — | — | US | disclosed |
| WO-2005019429-A2 | COMPOSITIONS AND METHODS FOR ENHANCING PHAGOCYTOSIS OR PHAGOCYTE ACTIVITY | POTENTIA PHARMACEUTICALS, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| WO-2004009553-A1 | PROCESS FOR PRODUCING 5-(2'-PYRIDYL)-2-PYRIDONE DERIVATIVE | KURARAY CO., LTD. (JP) | 2004-01-29 | — | — | WO | disclosed |
| EP-0210227-B1 | PYRIMIDINE SULFATES FOR HAIR GROWTH | THE UPJOHN COMPANY (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0210227-A1 | PYRIMIDINE SULFATES FOR HAIR GROWTH. | UPJOHN CO (US) | 1987-02-04 | — | — | EP | disclosed |
| WO-1986004231-A1 | PYRIMIDINE SULFATES FOR HAIR GROWTH | THE UPJOHN COMPANY (US) | 1986-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113297-A1 | Compositions and methods for enhancing phagocytosis or phagocyte activity | CD47, ANXA11, ANXA1 | LMNA 1911/4885KDM4E 3736/4885P4HTM 4054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.